ATX 2.20% 9.3¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 76 Posts.
    lightbulb Created with Sketch. 4
    I just don't see ATX will have enough data in P2A stage for any licensing agreement.
    They may have some early discussions with big pharma companies for now but that's all.

    I believe DXB were in discussions and negotiations for over a year prior to any deal.

    Last edited by Dimitrios63: 28/03/24
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
0.002(2.20%)
Mkt cap ! $33.31M
Open High Low Value Volume
9.5¢ 9.6¢ 9.2¢ $76.07K 809.9K

Buyers (Bids)

No. Vol. Price($)
3 85179 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 84560 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.